Q&A: Eurazeo's Eddie Chen
Eurazeo is a publicly-listed French private equity firm, formed in 2001 through the merger of Eurafrance and Azeo. China head Eddie Chen explains why the GP opened a Shanghai office five years ago
Q: What are the main functions of the Shanghai office? A: There are three parts. First, and we help them expand in Asia through M&A. Second, we look at cross-border deals that have an Asian angle and...
HKEX relaxes rules for IPOs by pre-profit tech companies
The Hong Kong Stock Exchange (HKEX) has loosened its listing requirements to allow pre-profit technology companies to go public with market capitalisations as low as HKD 6bn (USD 764m).
Asia GPs must get smarter on target selection, costs - Bain & Co
Careful target selection – based on geography and sector – and increased emphasis on cost controls during ownership will be critical factors for Asian private equity investors as the industry braces for a downturn, according to Bain & Company.
Longreach buys Japan healthcare SaaS player
North Asia buyout specialist The Longreach Group has invested an undisclosed sum in Wellness Communications Corporation (WCC), a Japanese healthcare software-as-a-service (SaaS) provider.
Asia-Europe investor AGIC supports Danish electronics buyout
AGIC Capital, a specialist in Europe-China cross-border deals, has backed the acquisition of PR Electronics, a Danish manufacturer of signal processing equipment with an existing base in China.